Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02136745 · ClinicalTrials.gov registry record · NA
Effects of Relaxation Response Mind-body Intervention in Patients With IBS and IBD
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT02136745: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02136745 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02136745, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
In this pilot study, the investigators examined whether a relaxation response mind-body intervention could be effectively delivered to mixed groups of IBS and IBD patients and determined the effects of the intervention on quality of life, inflammatory markers, and gene expression using transcriptional profiling.
Interventions
- BEHAVIORAL Relaxation Response Mind-Body Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02136745
The ClinicalTrials.gov registry entry for NCT02136745 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Relaxation Response Mind-Body Intervention is the first listed.
NCT02136745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02136745 about?
NCT02136745 is a clinical study titled "Effects of Relaxation Response Mind-body Intervention in Patients With IBS and IBD". In this pilot study, the investigators examined whether a relaxation response mind-body intervention could be effectively delivered to mixed groups of IBS and IBD patients and determined the effects of the intervention on quality of life, inflammatory markers, and gene expression using transcription...
What is the current status of trial NCT02136745?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2009-05. Estimated completion is 2011-07.
What interventions are being tested in trial NCT02136745?
The interventions under investigation include: Relaxation Response Mind-Body Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02136745?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.